As more players enter the spine robotics market, Keith Pfeil, CEO of Globus Medical is confident alongside larger competition, according to a first-quarter earnings call. Globus Medical had a strong first quarter with net sales growing 27% year over year,…
Spinal Tech
Carlsmed’s aprevo lumbar fusion implant could see increased CMS reimbursement under if its proposed 2027 rule goes into effect, according to a first-quarter earnings call. Aprevo’s lumbar fusion already has strong hospital reimbursement, Carlsmed CEO Michael Cordonnier said in a…
Spinal Resources earned its second U.S. patent for its multidiameter spinal fixation rod, according to a May 7 news release. U.S. Patent No. 12,611,231 extends the protections secured by the company’s first patent. Together they cover the company’s proprietary multi-diameter,…
Globus Medical reported $759.9 million in first-quarter net sales, a 27% increase year over year, according to financial results posted May 7. Five more notes: 1. Revenue gains were driven by share gains and volume strength in spine, Keith Pfeil,…
Aurora Spine earned its fourth U.S. patent supporting its Dexa bone density matching technology, according to a May 7 news release. U.S. Patent No. 12,605,252 B2 describes methods of btaining a patient’s bone density information, including a DEXA T-score or…
Advertisement
Alphatec saw $192 million in first-quarter sales, according to financial results posted May 5. Five things to know: 1. Revenue was up 13.5% year over year. 2. Surgical revenue was $178 million, a 17% increase year over year. This was…
Spine devicemaker Carlsmed saw massive year-over-year leaps in its first quarter revenue, according to financial results posted May 5. Five things to know: 1. First-quarter revenue reached $16.1 million, a 58% increase year over year. 2. Carlsmed saw gross profit…
Globus Medical CEO Keith Pfeil made $4.4 million in 2025, according to the company’s April 24 Securities and Exchange Commission proxy filing. Compensation packages for executives include salary, stock and option awards, non-equity incentive plan compensation, bonuses and other pay. Here…
Aclarion signed a second commercial agreement with New York City-based Weill Cornell Medicine, according to a May 5 news release. The new agreement brings Aclarion’s Nociscan spine diagnostic tool to Weill Cornell Medicine and Och Spine at NewYork-Presbyterian/Weill Cornell Medical…
Orthofix saw sales increases in the first quarter of 2026, according to financial results posted May 5. Six things to know: 1. Quarterly sales excluding the discontinued M6 disc was $196.4 million, a 3% increase year over year. 2. Spinal…